Stage IV melanoma vaccine (Adelaide Research & Innovation)
N/A
Report date: 2024/12/11 10:25:33
Base Information
Drug NameStage IV melanoma vaccine (Adelaide Research & Innovation)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Adelaide
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesUniversity Of Adelaide
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A